Glimepiride, Metformin SR (Sustained-Release), and Voglibose''';''''

Glimepiride, Metformin SR (Sustained-Release), and Voglibose SEIZMET TRIO are three different medications that are often used in the management of type 2 diabetes. They work in various ways to help control blood sugar levels. 
Glimepiride is a medication that belongs to the sulfonylurea class of drugs.
It works by stimulating the release of insulin from the pancreas and increasing the sensitivity of body tissues to insulin. This helps lower blood sugar levels.
Glimepiride is typically prescribed for people with type 2 diabetes to help control their blood sugar levels. It is usually taken orally in tablet form.
Metformin SR (Sustained-Release):
Metformin is a biguanide medication.
It works by decreasing the production of glucose by the liver and increasing the sensitivity of muscle cells to insulin. Metformin also reduces the absorption of glucose from the digestive tract.
Indication: Metformin is commonly prescribed as a first-line treatment for type 2 diabetes. The sustained-release form (Metformin SR) provides a slower release of the medication throughout the day, which may help reduce gastrointestinal side effects.
These side effects are often less severe with the sustained-release formulation.
Voglibose is an alpha-glucosidase inhibitor.
Mechanism of Action: It works by slowing down the digestion and absorption of carbohydrates in the intestines. This helps reduce post-meal spikes in blood sugar levels.
Indication: Voglibose is used to control blood sugar levels in people with type 2 diabetes, particularly after meals. It is usually taken orally in tablet form.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/seizmet-trio-0-3-133446